CCL Sept 2017 – NCI study identifies essential genes for cancer … – The Cancer Letter Publications
|
CCL Sept 2017 – NCI study identifies essential genes for cancer …
The Cancer Letter Publications A new NCI study has identified genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond … |
|
Novartis’s Kymriah becomes first gene therapy to get FDA approval
The Cancer Letter Publications The agent, sponsored by Novartis Pharmaceuticals Corp., was approved for pediatric and young adult patients with a form of acute lymphoblastic leukemia. On July 12, the FDA Oncologic Drugs Advisory Committee unanimously recommended that the agent … |
|
Novartis’s Kymriah becomes first gene therapy to get FDA approval
The Cancer Letter Publications The agent, sponsored by Novartis Pharmaceuticals Corp., was approved for pediatric and young adult patients with a form of acute lymphoblastic leukemia. On July 12, the FDA Oncologic Drugs Advisory Committee unanimously recommended that the agent … |
|
Synthetic Biology Market Research, Growth & Forecast to 2022
Medgadget (blog) Synthetic Biology Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $38.7 billion by 2020, registering aCAGR of 44.2% during the period 2014 – 2020.Europe occupies largest share in the global … |
|
GenSight Biologics to Attend Chardan Gene Therapy Conference
Markets Insider GenSight Biologics S.A. is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology … |
|
GenSight Biologics to Attend Chardan Gene Therapy Conference
Markets Insider GenSight Biologics S.A. is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology … |
The Republic |
Finding another way to fight cancer
The Republic Immunotherapy has become increasingly popular in the past five years, using the body’s immune system to fight cancer. This newer option for patients, in addition to the traditional chemotherapy and targeted therapy, is significantly different than the … |
ALS Research Forum |
A New CRISPR Technique Fries C9orf72 RNAs
ALS Research Forum “This is a highly innovative study that opens the exciting possibility of using CRISPR to specifically degrade repeat RNAs,” commented Fen-Biao Gao of the University of Massachusetts Medical School in Worcester, who was not involved in the study. “This … |